# Transplanted Murine Tumours SPECT Imaging with 99mTc Delivered with an Artificial Recombinant Protein

**Authors:** Natalia V. Pozdniakova, Alexey A. Lipengolts, Vsevolod A. Skribitsky, Kristina E. Shpakova, Yulia A. Finogenova, Anna V. Smirnova, Alexei B. Shevelev, Elena Y. Grigorieva

PMC · DOI: 10.3390/ijms251810197 · International Journal of Molecular Sciences · 2024-09-23

## TL;DR

This study explores using a custom protein to deliver a radioactive tracer for better tumor imaging in mice.

## Contribution

An artificial recombinant protein improves 99mTc tumor targeting and retention for SPECT/CT imaging.

## Key findings

- The T/N ratio for 99mTc-E1b increased over 24 hours, showing strong tumor retention.
- The protein-based tracer outperformed free 99mTc-pertechnetate in tumor selectivity.
- Results varied by tumor type, with higher T/N ratios observed in mammary adenocarcinomas.

## Abstract

99mTc is a well-known radionuclide that is widely used and readily available for SPECT/CT (Single-Photon Emission Computed Tomography) diagnosis. However, commercial isotope carriers are not specific enough to tumours, rapidly clear from the bloodstream, and are not safe. To overcome these limitations, we suggest immunologically compatible recombinant proteins containing a combination of metal binding sites as 99mTc chelators and several different tumour-specific ligands for early detection of tumours. E1b protein containing metal-binding centres and tumour-specific ligands targeting integrin αvβ3 and nucleolin, as well as a short Cys-rich sequence, was artificially constructed. It was produced in E. coli, purified by metal-chelate chromatography, and used to obtain a complex with 99mTc. This was administered intravenously to healthy Balb/C mice at an activity dose of about 80 MBq per mouse, and the biodistribution was studied by SPECT/CT for 24 h. Free sodium 99mTc-pertechnetate at the same dose was used as a reference. The selectivity of 99mTc-E1b and the kinetics of isotope retention in tumours were then investigated in experiments in C57Bl/6 and Balb/C mice with subcutaneously transplanted lung carcinoma (LLC) or mammary adenocarcinoma (Ca755, EMT6, or 4T1). The radionuclide distribution ratio in tumour and adjacent normal tissue (T/N) steadily increased over 24 h, reaching 15.7 ± 4.2 for EMT6, 16.5 ± 3.8 for Ca755, 6.7 ± 4.2 for LLC, and 7.5 ± 3.1 for 4T1.

## Linked entities

- **Proteins:** BCKDHB (branched chain keto acid dehydrogenase E1 subunit beta)
- **Diseases:** lung carcinoma (MONDO:0005138), mammary adenocarcinoma (MONDO:0004988)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Snora73a (small nucleolar RNA, H/ACA box 73a) [NCBI Gene 100306944] {aka E1, E1-7, E1b, U17A}, Nucleolin (nucleolin multifunctional protein) [NCBI Gene 17975] {aka B530004O11Rik, C23, D0Nds28, D1Nds28, Ncl, Nucl}
- **Diseases:** lung carcinoma (MESH:D008175), mammary adenocarcinoma (MESH:D000230), tumour (MESH:D009369)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Escherichia coli (E. coli, species) [taxon 562]
- **Cell lines:** Ca755 — Homo sapiens (Human), Osteosarcoma, Cancer cell line (CVCL_0892), EMT6 — Mus musculus (Mouse), Malignant neoplasms of the mouse mammary gland, Cancer cell line (CVCL_1923), 4T1 — Mus musculus (Mouse), Malignant neoplasms of the mouse mammary gland, Cancer cell line (CVCL_0125), LLC — Mus musculus (Mouse), Malignant tumors of the mouse pulmonary system, Cancer cell line (CVCL_5653)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11432708/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11432708/full.md

## References

39 references — full list in the complete paper: https://tomesphere.com/paper/PMC11432708/full.md

---
Source: https://tomesphere.com/paper/PMC11432708